Factors influencing the mortality risk of heart failure in patients receiving antineoplastic immunotherapy: A national inpatient database study 2016-2020

Authors

Purva Shah, Rochester Regional HealthFollow
Abdullah A. Orakzai, Rochester Regional HealthFollow
Himal Kharel, Rochester Regional HealthFollow
Aditya Sanjeevi, Rochester Regional HealthFollow
Basant Eltaher, Rochester Regional HealthFollow
Jose M. Easow, Apollo Cancer Specialty Hospital, Chennai, Tamil Nadu, India

Department

Internal Medicine

Document Type

Conference Proceeding

Publication Title

Journal of Clinical Oncology

Conference Name

American Society of Clinical Oncology (ASCO) Annual Meeting

Conference Date

2024-05-31 - 2024-06-04

First Page

e24011

DOI

10.1200/JCO.2024.42.16_suppl.e24011

Volume

42

Issue

16_suppl

Publication Date

6-1-2024

Recommended Citation

Shah, P., Orakzai, A. A., Kharel, H., Sanjeevi, A., Eltaher, B., & Easow, J. M. (2024). Factors influencing the mortality risk of heart failure in patients receiving antineoplastic immunotherapy: A national inpatient database study 2016-2020. Journal of Clinical Oncology, 42 (16_suppl), e24011. https://doi.org/10.1200/JCO.2024.42.16_suppl.e24011